Cramer Rosenthal McGlynn’s St Jude Medical STJ Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-628,592	Closed	-$39.7M	–	260
2015 Q3	$39.7M	Sell	628,592 -105,012	-14%	-$7.5M	0.54%	79
2015 Q2	$53.6M	Sell	733,604 -190,114	-21%	-$13.7M	0.66%	59
2015 Q1	$60.4M	Sell	923,718 -85,556	-8%	-$5.69M	0.68%	58
2014 Q4	$65.6M	Sell	1,009,274 -166,345	-14%	-$10.7M	0.67%	60
2014 Q3	$70.7M	Sell	1,175,619 -222,480	-16%	-$14.5M	0.71%	47
2014 Q2	$96.8M	Sell	1,398,099 -256,410	-15%	-$16.6M	0.78%	40
2014 Q1	$108M	Sell	1,654,509 -416,519	-20%	-$27.1M	0.83%	36
2013 Q4	$128M	Sell	2,071,028 -353,841	-15%	-$20.5M	0.92%	37
2013 Q3	$130M	Sell	2,424,869 -120,295	-5%	-$6.2M	0.98%	33
2013 Q2	$116M	Buy	+2,545,164	New	+$110M	0.88%	35

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Cramer Rosenthal McGlynn's STJ Position: Q4 2015 in Review

Cramer Rosenthal McGlynn sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 628,592 shares — an estimated $39.7M sold.

Cramer Rosenthal McGlynn first reported a position in STJ in Q2 2013 and held it in 10 quarters. The position peaked at $130M in Q3 2013. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

Cramer Rosenthal McGlynn reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
Cramer Rosenthal McGlynn sold 628,592 St Jude Medical shares in Q4 2015, an estimated $39.7M.
Cramer Rosenthal McGlynn first reported a position in St Jude Medical in Q2 2013 and held it in 10 quarters.
Cramer Rosenthal McGlynn's St Jude Medical position peaked at $130M in Q3 2013.
620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Cramer Rosenthal McGlynn's 13F filing for Q4 2015, filed 12 Feb 2016.